{"protocolSection":{"identificationModule":{"nctId":"NCT01436799","orgStudyIdInfo":{"id":"GIRBA2466"},"organization":{"fullName":"Gachon University Gil Medical Center","class":"OTHER"},"briefTitle":"Desflurane Versus Propofol in the Sitting Position","officialTitle":"International Review Board of Gachon University Gil Hospital"},"statusModule":{"statusVerifiedDate":"2013-08","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2011-03"},"primaryCompletionDateStruct":{"date":"2011-08","type":"ACTUAL"},"completionDateStruct":{"date":"2011-08","type":"ACTUAL"},"studyFirstSubmitDate":"2011-09-15","studyFirstSubmitQcDate":"2011-09-19","studyFirstPostDateStruct":{"date":"2011-09-20","type":"ESTIMATED"},"resultsFirstSubmitDate":"2013-02-05","resultsFirstSubmitQcDate":"2013-08-22","resultsFirstPostDateStruct":{"date":"2013-08-26","type":"ESTIMATED"},"lastUpdateSubmitDate":"2013-08-25","lastUpdatePostDateStruct":{"date":"2013-09-09","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Hyun Jeong Kwak","investigatorTitle":"Associate professor","investigatorAffiliation":"Gachon University Gil Medical Center"},"leadSponsor":{"name":"Gachon University Gil Medical Center","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"The investigators hypothesized that both propofol and desflurane would decrease the regional oxygen saturation (rSO2) but propofol is likely to reduce rSO2 more than sevoflurane when patients are raised to the sitting position.","detailedDescription":"The investigators hypothesized that both propofol and desflurane would decrease the rSO2 but propofol is likely to reduce rSO2 more than sevoflurane when patients are raised to the sitting position. Therefore, the purpose of this study was to investigate the effect of desflurane and propofol on rSO2 values during the beach chair position for shoulder arthroscopy."},"conditionsModule":{"conditions":["Cerebral Ischemia"],"keywords":["propofol","desflurane","cerebrovascular circulation","sitting"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"SINGLE","whoMasked":["INVESTIGATOR"]}},"enrollmentInfo":{"count":40,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Desflurane","type":"EXPERIMENTAL","description":"anaesthesia was induced with thiopental sodium 2 mg kg-1, alfentanil 10 μg kg-1 and rocuronium 0.6 mg kg-1. Anesthetic maintenance by desflurane","interventionNames":["Drug: Desflurane","Drug: alfentanil","Drug: Rocuronium"]},{"label":"propofol","type":"ACTIVE_COMPARATOR","description":"anaesthesia was induced with the effect-site concentration of propofol 5.0 μg ml-1, alfentanil 10 μg kg-1, and rocuronium 0.6 mg kg-1. A commercially available target controlled infusion (TCI) pump (Orchestra®, Fresenius Vial, France) was used and the pharmacokinetic set used to calculate target effect-site concentrations for propofol was Schnider and colleagues' model","interventionNames":["Drug: propofol","Drug: alfentanil","Drug: Rocuronium"]}],"interventions":[{"type":"DRUG","name":"propofol","description":"anaesthesia was induced with the effect-site concentration of propofol 5.0 μg ml-1 mainly.","armGroupLabels":["propofol"]},{"type":"DRUG","name":"Desflurane","description":"anaesthesia was maintained by desflurane 4-7vol%","armGroupLabels":["Desflurane"],"otherNames":["Des"]},{"type":"DRUG","name":"alfentanil","description":"administration of alfentanil 10 μg kg-1 for anesthetic induction","armGroupLabels":["Desflurane","propofol"],"otherNames":["alf"]},{"type":"DRUG","name":"Rocuronium","description":"administration of rocuronium 0.6 mg kg-1 for anesthetic induction","armGroupLabels":["Desflurane","propofol"],"otherNames":["roc"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Regional Cerebral Oxygen Satuation (rSO2)","description":"definitive values of regional cerebral oxygen saturation(rSO2,%) values are described as mean (SD)","timeFrame":"1, 3, 5, 7, and 9 min after the beach chair position"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Forty patients,\n* ASA class I or II,\n* undergoing shoulder arthroscopy\n\nExclusion Criteria:\n\n* Patients with history of cerebrovascular disease, coronary occlusive disease and/or obesity (body mass index \\> 30) were excluded from this study.","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Hyun Jeong Kwak, MD.PhD","affiliation":"Gachon University Gil Medical Center","role":"STUDY_DIRECTOR"}]}},"resultsSection":{"participantFlowModule":{"preAssignmentDetails":"no enrolled participants were excluded.","recruitmentDetails":"March 2011-August 2011 in Gachon University Gil Medical Center, who underwent arthroscopic shoulder surgery","groups":[{"id":"FG000","title":"Desflurane","description":"anaesthesia was induced with thiopental sodium 2 mg kg-1, alfentanil 10 μg kg-1 and rocuronium 0.6 mg kg-1. Anesthetic maintenance by desflurane"},{"id":"FG001","title":"Propofol","description":"anaesthesia was induced with the effect-site concentration of propofol 5.0 μg ml-1, alfentanil 10 μg kg-1, and rocuronium 0.6 mg kg-1. A commercially available target controlled infusion (TCI) pump (Orchestra®, Fresenius Vial, France) was used and the pharmacokinetic set used to calculate target effect-site concentrations for propofol was Schnider and colleagues' model"}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"20"},{"groupId":"FG001","numSubjects":"20"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"20"},{"groupId":"FG001","numSubjects":"20"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"Desflurane","description":"anaesthesia was induced with thiopental sodium 2 mg kg-1, alfentanil 10 μg kg-1 and rocuronium 0.6 mg kg-1. Anesthetic maintenance by desflurane"},{"id":"BG001","title":"Propofol","description":"anaesthesia was induced with the effect-site concentration of propofol 5.0 μg ml-1, alfentanil 10 μg kg-1, and rocuronium 0.6 mg kg-1. A commercially available target controlled infusion (TCI) pump (Orchestra®, Fresenius Vial, France) was used and the pharmacokinetic set used to calculate target effect-site concentrations for propofol was Schnider and colleagues' model"},{"id":"BG002","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"20"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"40"}]}],"measures":[{"title":"Age, Categorical","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"<=18 years","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]},{"title":"Between 18 and 65 years","measurements":[{"groupId":"BG000","value":"20"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"40"}]},{"title":">=65 years","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}]}]}]},{"title":"Age Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"48","spread":"10"},{"groupId":"BG001","value":"48","spread":"16"},{"groupId":"BG002","value":"48","spread":"14"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"15"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"25"}]}]}]},{"title":"Region of Enrollment","paramType":"NUMBER","unitOfMeasure":"participants","classes":[{"title":"Korea, Republic of","categories":[{"measurements":[{"groupId":"BG000","value":"20"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"40"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Regional Cerebral Oxygen Satuation (rSO2)","description":"definitive values of regional cerebral oxygen saturation(rSO2,%) values are described as mean (SD)","populationDescription":"A power analysis was calculated based on a previous study.14 In each group, 16 patients were needed to detect a mean intergroup difference of 5% in the rSO2 value with a power of 80% and a type I error of 0.05. To compensate for a dropout rate of 20%, 40 patients were included in this study.","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"percentage of rSO2 (%)","timeFrame":"1, 3, 5, 7, and 9 min after the beach chair position","groups":[{"id":"OG000","title":"Desflurane","description":"anesthetic maintenence with desflurane"},{"id":"OG001","title":"Propofol","description":"anesthetic maintanence with propofol"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"20"}]}],"classes":[{"title":"1min after beach chair position","categories":[{"measurements":[{"groupId":"OG000","value":"77.4","spread":"7"},{"groupId":"OG001","value":"72.5","spread":"9.5"}]}]},{"title":"3min after beach chair position","categories":[{"measurements":[{"groupId":"OG000","value":"76","spread":"7.1"},{"groupId":"OG001","value":"70","spread":"9.8"}]}]},{"title":"5min after beach chair position","categories":[{"measurements":[{"groupId":"OG000","value":"75.2","spread":"7.4"},{"groupId":"OG001","value":"70","spread":"8.5"}]}]},{"title":"7min after beach chair position","categories":[{"measurements":[{"groupId":"OG000","value":"75.1","spread":"7.2"},{"groupId":"OG001","value":"68.5","spread":"10.1"}]}]},{"title":"9min after beach chair position","categories":[{"measurements":[{"groupId":"OG000","value":"74","spread":"7.8"},{"groupId":"OG001","value":"67.8","spread":"9.8"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"0","timeFrame":"1, 3, 5, 7 and 9 min after the sitting position and postoperative 24hours","eventGroups":[{"id":"EG000","title":"Desflurane","description":"anaesthesia was induced with thiopental sodium 2 mg kg-1, alfentanil 10 μg kg-1 and rocuronium 0.6 mg kg-1. Anesthetic maintenance by desflurane","seriousNumAffected":0,"seriousNumAtRisk":20,"otherNumAffected":0,"otherNumAtRisk":20},{"id":"EG001","title":"Propofol","description":"anaesthesia was induced with the effect-site concentration of propofol 5.0 μg ml-1, alfentanil 10 μg kg-1, and rocuronium 0.6 mg kg-1. A commercially available target controlled infusion (TCI) pump (Orchestra®, Fresenius Vial, France) was used and the pharmacokinetic set used to calculate target effect-site concentrations for propofol was Schnider and colleagues' model","seriousNumAffected":0,"seriousNumAtRisk":20,"otherNumAffected":0,"otherNumAtRisk":20}]},"moreInfoModule":{"limitationsAndCaveats":{"description":"limitations of this study is that the ventilation was adjusted according to ETCO2 value instead of the arterial carbon dioxide tensions (PaCO2)."},"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":false},"pointOfContact":{"title":"Dr.HJ Kwak","organization":"Gachon University Gil Medical Center","email":"hyun615@gilhospital.com","phone":"82-32-460-3400"}}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000020521","term":"Stroke"},{"id":"D000007238","term":"Infarction"},{"id":"D000009336","term":"Necrosis"}],"browseLeaves":[{"id":"M10233","name":"Ischemia","asFound":"Ischemia","relevance":"HIGH"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Cerebral Ischemia","relevance":"HIGH"},{"id":"M5484","name":"Brain Ischemia","asFound":"Cerebral Ischemia","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"D000015760","term":"Alfentanil"},{"id":"D000015742","term":"Propofol"},{"id":"D000077335","term":"Desflurane"},{"id":"D000077123","term":"Rocuronium"}],"ancestors":[{"id":"D000006993","term":"Hypnotics and Sedatives"},{"id":"D000002492","term":"Central Nervous System Depressants"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000018686","term":"Anesthetics, Intravenous"},{"id":"D000018681","term":"Anesthetics, General"},{"id":"D000000777","term":"Anesthetics"},{"id":"D000003473","term":"Neuromuscular Nondepolarizing Agents"},{"id":"D000009466","term":"Neuromuscular Blocking Agents"},{"id":"D000009465","term":"Neuromuscular Agents"},{"id":"D000018373","term":"Peripheral Nervous System Agents"},{"id":"D000018685","term":"Anesthetics, Inhalation"},{"id":"D000000701","term":"Analgesics, Opioid"},{"id":"D000009294","term":"Narcotics"},{"id":"D000000700","term":"Analgesics"},{"id":"D000018689","term":"Sensory System Agents"}],"browseLeaves":[{"id":"M17997","name":"Propofol","asFound":"Infection","relevance":"HIGH"},{"id":"M1772","name":"Desflurane","asFound":"MAP","relevance":"HIGH"},{"id":"M3797","name":"Anesthetics","relevance":"LOW"},{"id":"M1666","name":"Rocuronium","asFound":"Capacity","relevance":"HIGH"},{"id":"M18010","name":"Alfentanil","asFound":"Accident","relevance":"HIGH"},{"id":"M16326","name":"Thiopental","relevance":"LOW"},{"id":"M9733","name":"Hypnotics and Sedatives","relevance":"LOW"},{"id":"M20456","name":"Anesthetics, Intravenous","relevance":"LOW"},{"id":"M20451","name":"Anesthetics, General","relevance":"LOW"},{"id":"M6374","name":"Neuromuscular Nondepolarizing Agents","relevance":"LOW"},{"id":"M12099","name":"Neuromuscular Blocking Agents","relevance":"LOW"},{"id":"M20455","name":"Anesthetics, Inhalation","relevance":"LOW"},{"id":"M3722","name":"Analgesics","relevance":"LOW"},{"id":"M3723","name":"Analgesics, Opioid","relevance":"LOW"},{"id":"M11935","name":"Narcotics","relevance":"LOW"}],"browseBranches":[{"abbrev":"CNSDep","name":"Central Nervous System Depressants"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"Analg","name":"Analgesics"},{"abbrev":"AntiConv","name":"Anticonvulsants"}]}},"hasResults":true}